earnings
confidence high
sentiment positive
materiality 0.80
Catalyst reports record FY2025 revenue $589M (+20% YoY); FY2026 guidance $615-645M
CATALYST PHARMACEUTICALS, INC.
2025-FY EPS
reported $1.68
vs consensus $0.34
▲ beat
(+390.2%)
- Full year 2025 total revenues $589.0M, up 19.8% YoY; GAAP diluted EPS $1.68 vs $1.31.
- Q4 2025 total revenues $152.6M; FIRDAPSE revenue grew 18.3% in Q4; AGAMREE grew 67.5%.
- FY2026 revenue guidance $615M-$645M; promoted product revenue expected to grow 20%+.
- Non-GAAP net income $346.2M for FY2025 vs $276.3M, up 25.3%.
- Cash and equivalents $709.2M as of Dec 31, 2025, up 37% YoY.